Tiova (Tiotropium) in Kenya

Product Description

Overview

Tiova is a long-acting muscarinic antagonist (LAMA) containing tiotropium bromide, used for maintenance treatment of COPD (Chronic Obstructive Pulmonary Disease) and asthma. It relaxes airway muscles by blocking acetylcholine receptors, improving breathing and reducing exacerbations. Available as Respimat inhaler (2.5mcg per actuation) and HandiHaler (18mcg capsules) in Kenya, it requires prescription and is not for acute relief.

Composition

• Respimat: Benzalkonium chloride, edetate disodium, purified water.
• HandiHaler: Lactose monohydrate (carrier).

Side Effects

Common

• Dry Mouth: Most frequent (due to anticholinergic effect).
• Throat Irritation: Cough, hoarseness.
• Headache, Dizziness: Mild and transient.
• Urinary Symptoms: Difficulty urinating (especially in elderly males with BPH).

Serious Risks

• Paradoxical Bronchospasm: Worsening wheezing (discontinue immediately).
• Glaucoma Precipitation: Acute angle-closure (avoid in predisposed patients).
• Urinary Retention: Risk in prostatic hyperplasia.
• Cardiovascular: Palpitations, tachycardia (rare).
• Allergic Reactions: Rash, angioedema.

How to Use

Respimat Inhaler

1. Prepare: Prime before first use (turn base until click; repeat 3 times).
2. Load: Insert cartridge; turn base until click.
3. Inhale: Breathe out fully; place mouthpiece; press dose-release button while inhaling slowly.
4. Hold Breath: 10 seconds.
5. Rinse Mouth: Prevents dry mouth/thrush.

HandiHaler

1. Load Capsule: Insert capsule into device; press buttons to pierce.
2. Inhale: Breathe out fully; seal lips around mouthpiece; inhale rapidly and deeply.
3. Hold Breath: 10 seconds.
4. Discard Capsule: Use once; discard empty capsule.

Dosing

• COPD/Asthma: 2 inhalations once daily (Respimat) or 1 capsule daily (HandiHaler).
• Timing: Same time daily; consistent use critical.
• Precautions:
  • Not for Rescue: Always carry short-acting bronchodilator (e.g., salbutamol).
  • Avoid if: Narrow-angle glaucoma, severe bladder obstruction, hypersensitivity.
  • Drug Interactions:
    • Other Anticholinergics (e.g., ipratropium): Additive side effects.
    • CYP3A4 Inhibitors (e.g., ketoconazole): Minimal interaction.

Frequently Asked Questions

1. Is Tiova available over-the-counter in Kenya?
   No – prescription-only by pulmonologists/physicians.

2. How much does it cost?
   Respimat: KES 4,000–6,000 per inhaler (60 doses). HandiHaler: KES 3,000–5,000 per pack (30 capsules).

3. Does NHIF cover it?
   Partially – covered for COPD under chronic illness scheme (co-payment required).

4. Can it be used for asthma attacks?
   No – maintenance only; use salbutamol for acute symptoms.

5. What if no improvement occurs?
   Check inhaler technique; consult doctor (may need add-on therapy like LABA/ICS).

6. Are there Kenyan alternatives?
   Yes – Spiriva (original tiotropium), Tiotrop (generic), or Incruse (glycopyrrolate).

7. Is it safe during pregnancy?
   Use only if essential – limited safety data (Category C).

8. How long does one inhaler/pack last?
   Respimat: 30 days (2 puffs/day). HandiHaler: 30 days (1 capsule/day).

Conclusion

Tiova is a first-line maintenance therapy for COPD and asthma in Kenya, offering once-daily dosing and reduced exacerbation risk. While partially NHIF-covered, cost and device technique challenges limit accessibility. Key advantages include minimal systemic absorption and steroid-free formulation, but anticholinergic side effects (dry mouth, urinary issues) require patient education. In Kenya’s high-pollution regions, Tiova mitigates exacerbations but demands strict adherence to inhaler technique and regular follow-ups. Always combine with smoking cessation (if applicable) and environmental trigger avoidance. For optimal outcomes, prioritize patient training on device use and emphasize that it is not a rescue medication.